Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co. is a globally renowned biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines. With a strong focus on serious diseases, the company's primary purpose is to address unmet medical needs in oncology, cardiovascular, immunoscience, and fibrosis through cutting-edge research and novel therapies. Bristol-Myers Squibb Co. is recognized for its portfolio of lifesaving medicines and commitment to patient-centric approaches, impacting various healthcare sectors including hospitals, private practices, and research institutions worldwide. The company's strategic collaborations and mergers, such as the notable acquisition of Celgene, have amplified its capabilities in biotechnology, bolstering its position as a leader in pharmaceuticals. Headquartered in New York City, Bristol-Myers Squibb Co. plays a pivotal role in the pharmaceutical market, steering advancements in medicine through continuous innovation and dedication to enhancing patient outcomes.